The Hiberx market is witnessing steady growth over the forecast period, supported by continued focus on child health outcomes, expansion of immunization access in emerging markets.
Read More
The Hexyon market is witnessing steady growth over the forecast period, supported by expansion of birth cohort immunization coverage, growth in emerging market vaccination programs.
Read More
The Heplisav-B market is witnessing steady growth over the forecast period, supported by expansion of adult vaccination mandates, increasing focus on diabetic and liver disease patients.
Read More
The Hepagam B market is witnessing steady growth over the forecast period, supported by strengthening public health policies, rising healthcare worker safety measures.
Read More
The Hemofil M market is witnessing steady growth over the forecast period, supported by expansion of hemophilia registries, growth in emerging market treatment access.
Read More
The viral arthritis vaccine market is projected to reach $11.09B by 2030, driven by next-gen vaccine platforms, emerging arboviruses, accelerated trials, and preventive immunization.
Read More
The targeted LNPs for extrahepatic delivery market is projected to reach $4.68B by 2030, driven by RNA therapeutics, tissue-specific delivery systems, ligand-directed nanoparticles, and modular nanocarrier platforms.
Read More
The systemic amyloidosis therapeutics market is projected to reach $8.88B by 2030, driven by targeted biologics, gene silencing therapies, monoclonal antibodies, and combination treatment protocols.
Read More
The super generics market is projected to reach $169.76B by 2030, driven by specialty generics, complex formulations, cost-effective therapies, and patient-friendly drug delivery innovations.
Read More
The single-use membrane chromatography systems market is projected to reach $1.96B by 2030, driven by gene and cell therapy growth, flexible purification adoption, and continuous bioprocessing innovations.
Read More